Source link : https://www.newshealth.biz/health-news/blood-test-unveils-disease-course-in-systemic-sclerosis/
TOPLINE: Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis (lcSSc), with patients having a high IFN activity presenting worse clinical outcomes. METHODOLOGY: Researchers conducted a longitudinal retrospective analysis to investigate whether the serum IFN score could predict clinically meaningful progression in patients with lcSSc using a novel composite […]
Author : News Health
Publish date : 2025-02-06 08:14:53
Copyright for syndicated content belongs to the linked Source.